Matches in Nanopublications for { ?s ?p "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP587468.RAmMeRqIMfT5iKwOAr3W7Rm4H08HMyZoaZLwvsvgFamvs130_assertion description "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587468.RAmMeRqIMfT5iKwOAr3W7Rm4H08HMyZoaZLwvsvgFamvs130_provenance.
- assertion description "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP520079.RAXHyAn9EkMGRmdDJxU4_qVLPC7id9bGDBeI7fIVentI8130_assertion description "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520079.RAXHyAn9EkMGRmdDJxU4_qVLPC7id9bGDBeI7fIVentI8130_provenance.
- NP520068.RA6seebveutOe9troq3xyxRQNIECDxOu-ae_cEui_fY54130_assertion description "[Our data document (a) the absence of BRAF mutations in cervical and endometrial cancer, despite the mutation status of KRAS, (b) suggest that KRAS mutations reflect an early event in endometrial carcinogenesis and (c) imply that BRAF activation is involving alternative pathways in these two types of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520068.RA6seebveutOe9troq3xyxRQNIECDxOu-ae_cEui_fY54130_provenance.